About this episode

This episode explores GLP-1 microdosing and its potential benefits for weight loss.

What is GLP-1 microdosing, and can smaller doses of medications like Ozempic, Wegovy, and Zepbound lead to better long-term weight loss results? In this episode, registered dietitian Zoe is joined by Deidre, FNP, to break down one of the biggest conversations in obesity medicine right now: GLP-1 microdosing. They explain how microdosing differs from standard manufacturer dosing, why FDA-approved dosing schedules are designed for clinical trials, and why a one-size-fits-all approach may not wo...

People in this episode

Host: Zoe

Guest: Deidre

Topics covered

• GLP-1 microdosing
• weight loss
• obesity medicine
• medication dosing
• long-term results

Keywords

• GLP-1
• microdosing
• Ozempic
• Wegovy
• Zepbound
• weight loss
• obesity medicine

Mentioned in this episode

Organizations: FDA

Products: Ozempic, Wegovy, Zepbound

More episodes of The Pound of Cure Weight Loss Podcast

• Medicare GLP-1 Bridge Program Explained: $50 Wegovy & Zepbound Access · July 2, 2026 · 36 min

Explore listener stats, chart rankings, contacts and more on the The Pound of Cure Weight Loss Podcast podcast page.